SEC Filing Summary

This filing details a Form 4 filing for BioCardia, Inc. (BCDA) concerning Jay M. Moyes, a director. On July 6, 2026, Mr. Moyes acquired 8,000 stock options with a right to buy common stock. These options have an exercise price of $1.20 and are set to expire on July 6, 2036. The options vest on the one-year anniversary of the grant date, contingent upon Mr. Moyes continuing as a service provider. Following this transaction, Mr. Moyes holds 23,573 shares. The filing was signed on July 7, 2026, by David McClung via power of attorney.